Chemical Structure (Alogliptin 01)
Alogliptin And Metformin Hydrochloride Tablet, Film Coated
Product Images NDC 45802-211
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Alogliptin And Metformin Hydrochloride (NDC 45802-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Alogliptin 02)
Figure 1 (Alogliptin 03)
Figure 2 (Alogliptin 04)
Figure 3 (Alogliptin 05)
This appears to be a table or figure from a clinical trial comparing the effects of placebo, alogliptin, metformin, and a combination of alogliptin and metformin on the treatment of an undisclosed condition. The table presents mean baseline values and changes in values for three dosing regimens of the drugs in question, with statistical significance noted for the combination therapy. No additional information about the study or condition is available in the text provided.*
Figure 4 (Alogliptin 06)
Principal Display Panel (12.5 mg/500 mg Tablet Bottle Label)
This is a medication that should not be accepted if the seal over the bottle is broken or missing and should be kept away from children. The usual dosage can be found in the package insert. Each film-coated tablet contains 17 mg of alogliptin benzoate equivalent to 12.5 mg of alogliptin and 500 mg metformin HCI. It should be stored at 25°C (77°F) and dispensed in a tightly closed container. Additionally, the medication comes with a medication guide and is distributed by Perrigo. The NDC number is 45802-169-72 and the product is Alogliptin and Metformin HCI Tablets, with a strength of 12.5mg/500mg. The bottle contains 60 tablets.*
Principal Display Panel (12.5 mg/1000 mg Tablet Bottle Label)
This is a medication that contains alogliptin benzoate and metformin HCI in the form of film-coated tablets. Users are warned not to accept the drug if the seal over the bottle opening is broken or missing. The usual dosage instructions can be found in the package insert. It is important to store the medication at a temperature range between 15°-30°C (59°-86°F) to maintain effectiveness. The drug should be kept out of reach of children and dispensed in a tightly closed container along with a medication guide. The distribution is handled by Perrigo with an address located in Allegan, MI. The NDC number for this medication is 45802-211-72.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
